Jupiter Wellness Seeks New Prescription Products For Issues In Breast Cancer Patients

Shivani Kumaresan

Tue, Sep 20, 2022, 2:49 PM1 min read

Jupiter Wellness Inc (NASDAQ: JUPW) has signed an exclusive licensing agreement with Rejoy Inc to develop prescription products for the treatment of nipple neuropathies for breast cancer patients.
The exclusive license includes issued patents and technology, including formulations.
Related: Jupiter Wellness Registers 400% Jump In Q2 Revenue
In clinical studies, one topical formulation improved nipple sensitivity and alleviated associated sexual problems.
The product has been named JW-500 to be added to a line of other clinical stage products currently under development.
Jupiter Wellness plans to file for a pre-IND meeting with the FDA within the next 12 months and intends to seek Orphan Drug Designation.
Price Action: JUPW shares are trading higher by 1.63% at $1.05 on the last check Tuesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

The Headache at the End of the Costco Gold Rush
Costco made buying a gold bar as simple as tossing it in a shopping cart. Adam Xi, 33 years old, called five different dealers to get a price he could accept for the gold bar he bought at Costco in October. Costco shoppers are spending as much as $200 million monthly on gold, according to a Wells Fargo estimate.
The Wall Street Journal•15h ago
Why Nvidia Stock Plunged 10% Today
Super Micro Computer's lack of a preliminary earnings report led to a bloodbath in the sector.
Motley Fool•6h ago
California loses 2 more property insurers in growing crisis
Two more property insurance companies are pulling out of California, leaving more homeowners in the state facing loss of coverage and surging premiums as insurers flee.
Fox Business•10h ago
Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Business Insider•1d ago
Super Micro Stock Plunges 23% On Lack Of Preliminary Results. It's A Big Sell Signal.
Super Micro stock fell hard after the data-center computer specialist didn't announce preliminary results for its fiscal Q3.
Investor's Business Daily•6h ago
Why Semiconductor Stocks Were Smacked Down Today
The high-flying sector caught a bit of gloom at the end of the week due to several discouraging developments.
Motley Fool•4h ago
Time to Pounce: 2 Superb Utility Stocks That Haven't Been This Cheap in at Least 10 Years
One of the fastest-growing utility stocks, along with "Wall Street's Greatest Dividend Stock," make for phenomenal buys right now.
Motley Fool•18h ago
Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Benzinga•2d ago
Trump Media CEO Decries Naked Short Selling; Citadel Fires Back, Stock Rises
Shares of Truth Social's parent rose in another volatile session, extending a roller-coaster stretch of trading for Donald Trump's social-media startup. On Thursday, Trump Media Chief Executive Devin Nunes sent a letter to Nasdaq CEO Adena Friedman asking her to help prevent illegal naked short selling and to make sure trading firms disclose their short positions.
The Wall Street Journal•7h ago
Apple Stock Is Falling. The CEO and Other Executives Just Sold Shares.
A variety of negative factors, including concern that the company is falling behind in AI, have hurt the stock.
Barrons.com•6h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Jupiter Wellness Seeks New Prescription Products For Issues In Breast Cancer Patients

Recommended Stories

The Headache at the End of the Costco Gold Rush

Why Nvidia Stock Plunged 10% Today

California loses 2 more property insurers in growing crisis

Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street

Super Micro Stock Plunges 23% On Lack Of Preliminary Results. It's A Big Sell Signal.

Why Semiconductor Stocks Were Smacked Down Today

Time to Pounce: 2 Superb Utility Stocks That Haven't Been This Cheap in at Least 10 Years

Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'

Trump Media CEO Decries Naked Short Selling; Citadel Fires Back, Stock Rises

Apple Stock Is Falling. The CEO and Other Executives Just Sold Shares.